Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
11/2013
11/13/2013CN103387548A 1,2,3-triazole antifungal compounds, and preparation method and application thereof
11/12/2013US8580970 Copper-catalysed ligation of azides and acetylenes
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013WO2013164838A1 Heterocyclic compounds and their use for treatment of diabetes, obesity or related disorders
11/07/2013US20130296389 Fungicide Active Substance Combinations
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130295040 Polymer
11/07/2013US20130295019 Ligands and methods for labeling biomolecules in vivo
11/06/2013EP2658846A2 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
11/06/2013CN103382186A 1-amino-3-alkyl-1, 2, 3-triazole nitrate and its synthesis method
11/06/2013CN101918376B 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
11/06/2013CN101772490B Trazodone and trazodone hydrochloride in purified form
11/05/2013US8575150 Triazole derivatives for treatment of Alzheimer's disease
10/2013
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/30/2013EP2655345A1 Aryl triazole compounds with antitumoural activity
10/30/2013EP2655295A1 Radioiodinated guanidines
10/30/2013CN103380119A Substituted aminobutyric derivatives as neprilysin inhibitors
10/30/2013CN103374125A Azobenzene and cinnamic acid ester group-containing side-chain-type liquid crystal polymer membrane material and synthetic method therefor
10/30/2013CN102558077B Process system capable of continuously producing methylbenzotriazole (TTA) and production method
10/29/2013US8569351 Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
10/29/2013US8569350 Anti-mitotic anti-proliferative compounds
10/29/2013US8568756 Inhibition of quorum sensing-mediated processes in bacteria
10/24/2013WO2013157311A1 Method for producing triazolyl methyl cycloalkanol derivative and triazolyl methyl cycloalkanol derivative-containing composition
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281499 Compounds
10/23/2013EP2651905A2 Metalloenzyme inhibitor compounds
10/23/2013EP2651900A1 Neprilysin inhibitors
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013CN103370309A Substituted N-phenethyltriazoloneacetamides and use thereof
10/23/2013CN103370306A Glucagon receptor modulator
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563651 Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
10/22/2013US8563526 Triazole derivatives, their preparation and their application in therapeutics
10/22/2013US8563512 Neprilysin inhibitors
10/17/2013US20130274298 Azole compounds used as tuberculostatic and leishmanicide agents
10/16/2013CN103351349A Synthetic method for benzotriazole ultraviolet absorbent UV-P
10/15/2013US8558013 Electroluminescent materials
10/10/2013WO2013152206A1 Novel triazole compounds that modulate hsp90 activity
10/10/2013WO2013151597A2 (1,2,3-triazolyl) sulfonyl derivatives
10/10/2013WO2013150486A1 Radiotracers, preparation methods and applications
10/10/2013US20130267572 Plymorphic Forms of Deferasirox (ICL670A)
10/10/2013US20130267568 (1,2,3-Triazolyl)sulfonyl Derivatives
10/09/2013CN103347886A Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device
10/09/2013CN103347862A Method including latent 1,3-dipole-functional compound and material prepared thereby
10/09/2013CN103342684A 2-(2'-hydroxyl-ethoxyl-ethoxyl)-2H-benzotriazole as well as synthesis and corrosion inhibition application thereof
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/08/2013US8552043 N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors
10/08/2013US8552039 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
10/08/2013US8551980 Substituted triazolopyridines
10/08/2013US8551625 Derivative with heteroaromatic ring, and light-emitting element, light-emitting device, lighting device, and electronic device using derivative with heteroaromatic ring
10/08/2013CA2721222C Fungicidal active compound combinations
10/03/2013WO2013144234A1 1,2,4 -triazole derivatives as herbicidals
10/03/2013WO2013144224A1 Acetylenic microbiocides
10/02/2013EP2644601A1 Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
10/02/2013EP2643306A1 Process for the preparation of deferasirox
10/02/2013EP2643292A1 Calcium-sensing receptor-active compounds
10/02/2013CN103339115A Metalloenzyme inhibitor compounds
10/02/2013CN103333728A Corrosion-resistant lubricant
10/02/2013CN103333127A Synthetic method for N-vinyl-triazole compound
10/02/2013CN102093251B Non-peptide juvenile hormone synthetic inhibitor
10/01/2013US8546581 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
10/01/2013US8546563 Compounds which modulate the CB2 receptor
10/01/2013US8546437 Compounds and compositions and methods of use
10/01/2013US8546436 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
10/01/2013US8546435 Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
10/01/2013US8546434 Triazole compounds as KSP inhibitors
10/01/2013US8546432 Tetrazolones as inhibitors of fatty acid synthase
10/01/2013CA2594384C Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
09/2013
09/26/2013US20130252964 Compounds And Methods For Treating Candidiasis And Aspergillus Infections
09/25/2013EP2640711A2 Improved process for the preparation of rufinamide
09/25/2013CN103328452A Metalloenzyme inhibitor compounds
09/24/2013US8541625 Cyclopropenones and the photochemical generation of cyclic alkynes therefrom
09/24/2013US8541402 Viral polymerase inhibitors
09/19/2013US20130245260 Neprilysin inhibitors
09/19/2013US20130245084 Calcium-sensing receptor-active compounds
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130245019 Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition
09/19/2013US20130244267 Compositions and methods for quadricyclane modification of biomolecules
09/19/2013US20130243727 Triazoles as inhibitors of fatty acid synthase
09/18/2013EP2639228A2 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
09/18/2013EP2638021A2 Metalloenzyme inhibitor compounds
09/18/2013CN102395556B Carboxylate compound and use thereof
09/18/2013CN102153481B Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
09/17/2013US8536209 Aminotriazole derivatives as ALX agonists
09/17/2013US8536202 Triazole-substituted anthranilamides as pesticides
09/12/2013WO2013134562A1 Triazolone compounds and uses thereof
09/12/2013WO2013134376A1 Positive allosteric modulators for melanocortin receptors
09/12/2013WO2013133343A1 Fluorine-containing α,β-unsaturated aldehyde, method for producing same, optically active fluorine-containing compound using fluorine-containing α,β-unsaturated aldehyde, and method for producing same
09/12/2013WO2013131872A1 Imaging neural activity
09/12/2013US20130237573 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS
09/11/2013EP2635280A2 Cytosine deaminase modulators for enhancement of dna transfection
09/11/2013EP2635275A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
09/11/2013CN103298796A Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
09/11/2013CN103298795A Pure intermediate for preparing letrozole
09/11/2013CN103289664A Acid liquor corrosion inhibitor for inhibiting corrosion of hydrochloric acid solution on carbon steel and preparation method thereof
09/11/2013CN103288766A Triazole compound, and preparation method and application thereof
09/11/2013CN103288765A Synthetic method of NH-1, 2, 3-triazole compound
09/11/2013CN101391985B Triazole onium compound with antimicrobial activity, preparation method and medical use
09/11/2013CN101151255B 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 178